FILE - This Oct. 14, 2015 file photo shows the Food & Drug Administration campus in Silver Spring, Md. On Friday, March 8, 2019, the FDA approved Roche’s Tecentriq, the first cancer immunotherapy for treating an aggressive type of breast cancer. (AP Photo/Andrew Harnik, File)
Rookie QB Daniels stars again in desert return, Commanders beat Cardinals 42-14 for 3rd straight Shares
Rescuers race to free people trapped by Hurricane Helene after storm kills at least 40 in 4 states Shares